Annual total expenses:
$553.80M+$32.23M(+6.18%)Summary
- As of today (September 16, 2025), TVTX annual total expenses is $553.80 million, with the most recent change of +$32.23 million (+6.18%) on December 31, 2024.
- During the last 3 years, TVTX annual total expenses has risen by +$146.22 million (+35.88%).
- TVTX annual total expenses is now at all-time high.
Performance
TVTX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$127.20M+$4.25M(+3.45%)Summary
- As of today (September 16, 2025), TVTX quarterly total expenses is $127.20 million, with the most recent change of +$4.25 million (+3.45%) on June 30, 2025.
- Over the past year, TVTX quarterly total expenses has increased by +$3.44 million (+2.78%).
- TVTX quarterly total expenses is now -28.27% below its all-time high of $177.33 million, reached on March 31, 2024.
Performance
TVTX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TVTX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.2% | +2.8% |
| 3 y3 years | +35.9% | +5.0% |
| 5 y5 years | +72.1% | +70.8% |
TVTX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.9% | -28.3% | +13.4% |
| 5 y | 5-year | at high | +72.1% | -28.3% | +72.6% |
| alltime | all time | at high | +3292.9% | -28.3% | +264.0% |
TVTX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $127.20M(+3.5%) |
| Mar 2025 | - | $122.96M(-9.0%) |
| Dec 2024 | $553.80M(+6.2%) | $135.06M(+14.8%) |
| Sep 2024 | - | $117.65M(-4.9%) |
| Jun 2024 | - | $123.77M(-30.2%) |
| Mar 2024 | - | $177.33M(+32.7%) |
| Dec 2023 | $521.57M(+18.3%) | $133.66M(+5.8%) |
| Sep 2023 | - | $126.34M(-13.1%) |
| Jun 2023 | - | $145.33M(+14.0%) |
| Mar 2023 | - | $127.45M(+10.9%) |
| Dec 2022 | $440.93M(+8.2%) | $114.97M(+2.5%) |
| Sep 2022 | - | $112.14M(-7.5%) |
| Jun 2022 | - | $121.20M(-2.6%) |
| Mar 2022 | - | $124.46M(+14.4%) |
| Dec 2021 | $407.58M(+10.8%) | $108.82M(+4.8%) |
| Sep 2021 | - | $103.86M(+10.9%) |
| Jun 2021 | - | $93.63M(-7.5%) |
| Mar 2021 | - | $101.27M(-41.3%) |
| Dec 2020 | $367.75M(+14.3%) | $172.60M(+134.2%) |
| Sep 2020 | - | $73.69M(-1.1%) |
| Jun 2020 | - | $74.50M(+58.6%) |
| Mar 2020 | - | $46.96M(-39.0%) |
| Dec 2019 | $321.76M(+20.5%) | $76.95M(-4.8%) |
| Sep 2019 | - | $80.86M(-3.1%) |
| Jun 2019 | - | $83.41M(+3.6%) |
| Mar 2019 | - | $80.55M(+57.2%) |
| Dec 2018 | $266.92M(+24.3%) | $51.23M(-46.2%) |
| Sep 2018 | - | $95.22M(+49.6%) |
| Jun 2018 | - | $63.67M(+12.1%) |
| Mar 2018 | - | $56.81M(-5.0%) |
| Dec 2017 | $214.67M | $59.80M(+2.9%) |
| Sep 2017 | - | $58.13M(+11.7%) |
| Jun 2017 | - | $52.03M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $44.71M(-2.7%) |
| Dec 2016 | $181.49M(-1146.4%) | $45.93M(-35.4%) |
| Sep 2016 | - | $71.06M(+52.1%) |
| Jun 2016 | - | $46.71M(+162.6%) |
| Mar 2016 | - | $17.79M(-45.9%) |
| Dec 2015 | -$17.34M(-112.5%) | $32.92M(-142.4%) |
| Sep 2015 | - | -$77.57M(-256.4%) |
| Jun 2015 | - | $49.59M(-322.6%) |
| Mar 2015 | - | -$22.28M(-151.7%) |
| Dec 2014 | $139.14M(+301.9%) | $43.11M(+54.5%) |
| Sep 2014 | - | $27.90M(-1118.0%) |
| Jun 2014 | - | -$2.74M(-103.9%) |
| Mar 2014 | - | $70.65M(+451.0%) |
| Dec 2013 | $34.62M(+14.1%) | $12.82M(+17.7%) |
| Sep 2013 | - | $10.90M(+115.9%) |
| Jun 2013 | - | $5.05M(+6.4%) |
| Mar 2013 | - | $4.74M(-84.4%) |
| Dec 2012 | $30.34M(>+9900.0%) | $30.33M(>+9900.0%) |
| Nov 2011 | - | $3500.00(0.0%) |
| Aug 2011 | - | $3500.00(0.0%) |
| May 2011 | - | $3500.00(-14.6%) |
| Feb 2011 | $23.00K(-17.9%) | $4100.00(-28.1%) |
| Nov 2010 | - | $5700.00(-13.6%) |
| Aug 2010 | - | $6600.00(0.0%) |
| May 2010 | - | $6600.00(-5.7%) |
| Feb 2010 | $28.00K(+53.0%) | $7000.00(+6.1%) |
| Nov 2009 | - | $6600.00(-1.5%) |
| Aug 2009 | - | $6700.00(-11.8%) |
| May 2009 | - | $7600.00(0.0%) |
| Feb 2009 | $18.30K(-64.8%) | $7600.00(+76.7%) |
| Nov 2008 | - | $4300.00(+38.7%) |
| Aug 2008 | - | $3100.00(-8.8%) |
| May 2008 | - | $3400.00 |
| Feb 2008 | $52.00K | - |
FAQ
- What is Travere Therapeutics, Inc. annual total expenses?
- What is the all time high annual total expenses for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual total expenses year-on-year change?
- What is Travere Therapeutics, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly total expenses year-on-year change?
What is Travere Therapeutics, Inc. annual total expenses?
The current annual total expenses of TVTX is $553.80M
What is the all time high annual total expenses for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual total expenses is $553.80M
What is Travere Therapeutics, Inc. annual total expenses year-on-year change?
Over the past year, TVTX annual total expenses has changed by +$32.23M (+6.18%)
What is Travere Therapeutics, Inc. quarterly total expenses?
The current quarterly total expenses of TVTX is $127.20M
What is the all time high quarterly total expenses for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly total expenses is $177.33M
What is Travere Therapeutics, Inc. quarterly total expenses year-on-year change?
Over the past year, TVTX quarterly total expenses has changed by +$3.44M (+2.78%)